Metformin and cancer hallmarks: shedding new lights on therapeutic repurposing - Journal of Translational Medicine

  • 📰 BioMedCentral
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 71%

Energy Energy Headlines News

Energy Energy Latest News,Energy Energy Headlines

A Review in the Journal of Translational Medicine discusses the possible molecular mechanisms of metformin in cancer prevention and treatment, its role in terms of cancer hallmarks, current challenges, and future directions in clinical translation.

] recently defined the inhibitory drug-target interactions of metformin with mammalian respiratory complex I by combining cryo-electron microscopy and enzyme kinetics. The identification of the direct target of metformin’s anticancer effects may help to further investigation for drug development. Second, in in vitro research, the direct effects are emphasized and well-studied, while the indirect effects cannot be mimicked.

]. We expect more in vivo models with more complex designs that are currently used in most in vitro research.There is a discrepancy in the antitumor effect of metformin between clinical research and preclinical studies, although metformin has shown notable benefits for cancer prevention and treatment in preclinical research, and the related molecular mechanisms have been extensively studied.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 22. in ENERGY

Energy Energy Latest News, Energy Energy Headlines